Avalyn Pharma Inc (AVLN)

Over the past 90 days, Avalyn Pharma Inc. recorded four insider buy transactions totaling approximately $25 million. Three distinct insiders, including SR One Capital Management, LLC and Novo Holdings A/S, executed these purchases on May 1, 2026. No insider selling activity was reported during this period, despite the company's recent stock price decline and negative earnings report.
Ticker: AVLN Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Novo Holdings A/S
1 purchase — total 9,999,990 USD
Buy 1 May 2026
Value US$530,390.47 | Price 121.37 | Shares 55,432
Buy 1 May 2026
Value US$3,200,751.58 | Price 143.51 | Shares 19,977
Buy 1 May 2026
Value US$4,999,986.00 | Price 18.00 | Shares 277,777
Buy 1 May 2026
Value US$5,000,004.00 | Price 18.00 | Shares 277,778
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-05 2026-05-01 B Purchase Large shareholder
55,432 +22.4%
121.37
US$530,390
55,432 +22.4% 121.37 US$530,390
2026-05-01 2026-05-01 B Purchase Non-Executive Director
19,977 -9.8%
143.51
US$3,200,752
19,977 -9.8% 143.51 US$3,200,752
2026-05-01 2026-05-01 B Purchase Large shareholder
61,796 +36.5%
378.27
US$1,613,353
61,796 +36.5% 378.27 US$1,613,353
2026-05-01 2026-05-01 B Purchase Large shareholder
277,778 +14.6%
18.00
US$5,000,004
277,778 +14.6% 18.00 US$5,000,004